The final stage of clinical trials of the coronavirus vaccine, conducted by the Gamalei National Research Center and the Defense Ministry, has begun, the Military Department reported.
Tests began on June 18. Nine participants in the experiment were given one component of the vaccine, and nine more were given the second component.
Later, on June 23, 20 more volunteers received the vaccine. They will test the drug in a booster version — they will later be injected with the second component of the vaccine.
The first group will be released on July 15 after passing control tests, and they will return to their places of work. Now their condition is good, "complaints about health, negative reactions or adverse events are not noted."
The second group of volunteers will take the second component on July 13, which should help to strengthen immunity, the Agency explains.
The data obtained, as noted, "indicate the formation of the first and second groups of volunteers of the immune response to the COVID-19 coronavirus vaccine."
GSV "Russia - Islamic World"
Photo: Michal Jarmoluk / Pixabay
Based on materials from RIA Novosti